Target Name: Calcium-Activated K(Ca) Potassium Channel
NCBI ID: P11022
Review Report on Calcium-Activated K(Ca) Potassium Channel Target / Biomarker Content of Review Report on Calcium-Activated K(Ca) Potassium Channel Target / Biomarker
Calcium-Activated K(Ca) Potassium Channel
Other Name(s): None

Calcium-Activated K(Ca) Potassium Channel: A Promising Drug Target and Biomarker

Abstract:

Calcium-activated K(Ca) potassium channels (nonspecific subtype) play a crucial role in various physiological processes, including muscle contractions, nerve impulse conduction, and intracellular signaling. Dysregulation of these channels has been implicated in numerous neurological and physiological disorders, making them an attractive drug target and biomarker. In this article, we will discuss the structure, function, and potential therapeutic applications of calcium-activated K(Ca) potassium channels, with a focus on their potential as drug targets and biomarkers.

Structure and Function:

Calcium-activated K(Ca) potassium channels are a type of voltage-dependent ion channel that plays a central role in intracellular signaling. These channels are characterized by their high sensitivity to changes in membrane potential and the rapid formation of the channels during muscle or nerve contractions. They are expressed in a variety of tissues, including muscle, nerve, and heart, and are involved in the regulation of various physiological processes, including muscle contractions, nerve impulse conduction, and intracellular signaling.

One of the unique features of calcium-activated K(Ca) potassium channels is their ability to store electrical charge on their membranes. This property is critical for their function, as it allows them to play a central role in intracellular signaling. During muscle or nerve contractions, the channels store a positive charge on their membranes, which is then rapidly released to help initiate the muscle or nerve contractions. This process is known as rapid depolarization and is critical for the initiation of the muscle or nerve contractions.

In addition to their role in intracellular signaling, calcium-activated K(Ca) potassium channels are also involved in the regulation of external stimuli, such as changes in membrane potential. This property makes them an attractive drug target, as they can be manipulated to modulate various physiological processes. For example, changes in membrane potential can be used to treat epilepsy, and changes in the channel's activity can be used to treat chronic pain.

Potential Therapeutic Applications:

The potential therapeutic applications of calcium-activated K(Ca) potassium channels are vast and range from the treatment of epilepsy and chronic pain to the regulation of various physiological processes.

1. Drug Targets:

a. Calcium-Activated K(Ca) Potassium Channels as a Drug Target:

Calcium-activated K(Ca) potassium channels have been identified as potential drug targets for a variety of diseases, including epilepsy, migraine, and chronic pain. These channels can be modulated to reduce their activity, leading to the improvement of various physiological processes. For example, inhibition of calcium-activated K(Ca) potassium channels has been shown to be effective in treating epilepsy by reducing the spread of electrical activity in the brain. Additionally, modulation of these channels has been shown to be effective in treating migraine by reducing the intensity of neural activity in the brain.

b. Calcium-Activated K(Ca) Potassium Channels as a Biomarker:

Calcium-activated K(Ca) potassium channels have also been identified as potential biomarkers for a variety of diseases. For example, changes in the channel's activity can be used as a biomarker for neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. Additionally, the rapid formation of calcium-activated K(Ca) potassium channels during muscle or nerve contractions can be used as a biomarker for certain types of muscle and nerve disorders, such as myasthenia gravis.

2. Antagonists:

Antagonists of calcium-activated K(Ca) potassium channels have been

Protein Name: Calcium-Activated K(Ca) Potassium Channel (nonspecified Subtype)

The "Calcium-Activated K(Ca) Potassium Channel Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Calcium-Activated K(Ca) Potassium Channel comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

CALCOCO1 | CALCOCO2 | CALCR | CALCRL | CALCRL-AS1 | CALD1 | CALHM1 | CALHM2 | CALHM3 | CALHM4 | CALHM5 | CALHM6 | CALM1 | CALM2 | CALM2P1 | CALM2P2 | CALM3 | CALML3 | CALML3-AS1 | CALML4 | CALML5 | CALML6 | Calmodulin | CALN1 | Calpain | Calpain-13 | Calprotectin | CALR | CALR3 | CALU | CALY | CAMK1 | CAMK1D | CAMK1G | CAMK2A | CAMK2B | CAMK2D | CAMK2G | CAMK2N1 | CAMK2N2 | CAMK4 | CAMKK1 | CAMKK2 | CAMKMT | CAMKV | CAMLG | CAMP | cAMP Phosphodiesterase | cAMP Responsive Element Binding Protein (CREB) | cAMP-Dependent protein kinase (PKA) | CAMSAP1 | CAMSAP2 | CAMSAP3 | CAMTA1 | CAMTA2 | CAND1 | CAND1.11 | CAND2 | Cannabinoid receptor | CANT1 | CANX | Cap-binding complex | CAP1 | CAP2 | CAPG | CAPN1 | CAPN10 | CAPN10-DT | CAPN11 | CAPN12 | CAPN13 | CAPN14 | CAPN15 | CAPN2 | CAPN3 | CAPN5 | CAPN6 | CAPN7 | CAPN8 | CAPN9 | CAPNS1 | CAPNS2 | CAPRIN1 | CAPRIN2 | CAPS | CAPS2 | CAPSL | CAPZA1 | CAPZA2 | CAPZA3 | CAPZB | Carbonic Anhydrase | Carbonic Anhydrase V | Carboxylesterase | Carboxypeptidase A | Carboxypeptidase B | Carboxypeptidase N | Carcinoembryonic Antigen-Related Cell Adhesion Molecule (CEA) | CARD10 | CARD11